Engineering light-controllable CAR T cells for cancer immunotherapy
Science advances, 2020.
T cells engineered to express chimeric antigen receptors (CARs) can recognize and engage with target cancer cells with redirected specificity for cancer immunotherapy. However, there is a lack of ideal CARs for solid tumor antigens, which may lead to severe adverse effects. Here, we developed a light-inducible nuclear translocation and di...More
Full Text (Upload PDF)
PPT (Upload PPT)